Cat. #153648
Anti-Inhibin a [PO23/32]
Cat. #: 153648
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: Inhibin a
Class: Monoclonal
Application: ELISA
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: BioServ UK Ltd
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-Inhibin a [PO23/32]
- Alternate name: Inhibin alpha chain, INHA
- Research fields: Cancer;Cell signaling and signal transduction
- Clone: PO 23/32
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 40 kDa
- Strain: Balb/c
- Reactivity: Human
- Host: Mouse
- Application: ELISA
- Description: Higher levels of inhibin ÄÂ? have been associated with a higher risk of cancer progression and recurrence. Clone PO 23/32 is useful in detecting inhibin ÄÂ? levels in cancer cells.
- Immunogen: Synthetic peptide corresponding to epitope region aa109-123 of the aC region of a subunit of inhibin A
- Isotype: IgG2a
- Myeloma used: Sp2/0-Ag14
- Recommended controls: Testis or Ovary
Target Details
- Target: Inhibin a
- Molecular weight: 40 kDa
- Tissue cell line specificity: Testis or Ovary
- Target background: Higher levels of inhibin a have been associated with a higher risk of cancer progression and recurrence. Clone PO 23/32 is useful in detecting inhibin a levels in cancer cells.
Applications
- Application: ELISA
Handling
- Format: Liquid
- Unit size: 100 ug
- Shipping conditions: Dry ice
References
- Robertson et al. 2002. J Clin Endocrinol Metab. 87(2):816-24. PMID: 11836327.
- Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer.
- Robertson et al. 2001. Mol Cell Endocrinol. 180(1-2):79-86. PMID: 11451575.
- Development of an inhibin alpha subunit ELISA with broad specificity.
![Anti-Inhibin a [PO23/32]](https://cancertools.org/wp-content/uploads/12dfc5c4-405b-4206-976e-b9498e3e9a8c.png)
![Anti-Inhibin a [PO23/32] - Image 2](https://cancertools.org/wp-content/uploads/6be08462-8775-40ef-88cf-8da5d8cc0559.png)


![Anti-CAR Whitlow Linker [1C3C3]](https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-300x322.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-280x300.jpg 280w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-954x1024.jpg 954w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-768x824.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 1193w)

